Clinical Trials

Overview

About this study

The purpose of this study is to explore the level of similarity in pharmacodynamic responses to GUCY2C agonists in organoids prepared from rectal biopsies from all healthy subjects, independent of changes in their bowel movements induced by oral administration of 27 mg/day of dolcanatide for 7 days.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

More information